Physician profile
Jeffrey Lee
NPI 1962956409
$2,158.84
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $298 · 2022: $1,821 · 2023: $39.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $886.08 | 2021-2022 | |
| Novo Nordisk INC | $398.68 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $359.35 | 2022 | |
| Lilly USA, LLC | $225.11 | 2021-2022 | |
| Horizon Therapeutics Plc | $110.25 | 2022 | |
| Dexcom, INC. | $55.79 | 2021-2023 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $33.75 | 2022 | |
| Insulet Corporation | $27.68 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $18.26 | 2022 | |
| Ibsa Pharma INC. | $15.18 | 2022 | |
| Abbott Laboratories | $14.93 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.